Charles Loprinzi
Mayo Clinic School of Graduate Medical Education

Last Updated On 9/28/2023 10:21:17 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Metys Pharmaceuticals
Recipient: You
Company: DISARM Pharmaceuticals
Recipient: You
Company: Onquality
Recipient: You
Company: NKMax
Recipient: You
Company: Mitsubishi Tanabe Pharma
Recipient: You
Company: Veloxis
Recipient: You
Company: Metys Pharmaceuticals
Recipient: You
Company: Hengrui Pharmaceutical
Recipient: You
Company: Osmol Therapeutics
Recipient: You
Company: Gruenthal
Recipient: You
Company: Neuropathix
Recipient: You
Company: Denali Therapeutics
Recipient: You
Company: Bexion
Recipient: You
Company: Veloxis
Recipient: You
Company: Vevro
Recipient: You
Company: Galendia
Recipient: You
Company: Hengrui Pharmaceuticals
Recipient: You
Company: Neuropathix
Recipient: You
Company: Neuropathix
Recipient: You
Company: Denali Therapeutics
Recipient: You
Company: Bexion
Recipient: You
Company: Bexion
Recipient: You
Company: Bexion
Recipient: You
Company: Genentech
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Bristol-Myers Squibb
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
not answered